HN2002000350A - Combinacion de una forma de farmaco cristalina y una sal de tiotropio - Google Patents

Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Info

Publication number
HN2002000350A
HN2002000350A HN2002000350A HN2002000350A HN2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A
Authority
HN
Honduras
Prior art keywords
salt
combination
tiotropio
farmaco
crystal
Prior art date
Application number
HN2002000350A
Other languages
English (en)
Original Assignee
Inc Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc Pfizer filed Critical Inc Pfizer
Priority to HN2002000350A priority Critical patent/HN2002000350A/es
Publication of HN2002000350A publication Critical patent/HN2002000350A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMBINACION DE UNA FORMA CRISTALINA DE 6-[(2,2- DIFENILETIL)AMINO] - 9- (N-ETIL-B-D-RIBOFURANOSIL - URONAMIDA)-N- (2- {N´ -[ 1-(2-PIRIDIL) - 4- PIPERIDIL] UREIDO} ETIL)-9H-PURIN-2-CARBOXAMIDA Y A UNA SAL DE TIOTROPIO.
HN2002000350A 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio HN2002000350A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2002000350A HN2002000350A (es) 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2002000350A HN2002000350A (es) 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Publications (1)

Publication Number Publication Date
HN2002000350A true HN2002000350A (es) 2003-07-23

Family

ID=53183918

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000350A HN2002000350A (es) 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Country Status (1)

Country Link
HN (1) HN2002000350A (es)

Similar Documents

Publication Publication Date Title
WO2003079986A3 (en) Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
WO2007048065A3 (en) Pyrimidinones as casein kinase ii (ck2) modulators
AU2003223012A1 (en) Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
AU2003231231A1 (en) Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
AU2002341942A1 (en) Sugar modified nucleosides as viral replication inhibitors
CO4940418A1 (es) Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
IL175123A0 (en) Crystalline ammonium salts of rosuvastatin
AP2006003551A0 (en) Combinations of a pyrimidine containing NNRTI withRT inhibitors.
ZA200501418B (en) Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
AU2003232960A1 (en) 4-4(methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating mutated-ret kinase associated diseases
WO2003016248A3 (en) Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
AU2003223637A1 (en) Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl) -n-pentanoyl-n- (2'-(1h-tetrazol-5-yl-)- biphenyl-4-yl methyl) amine (valsartan)
AU2003211427A1 (en) Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
IL161842A0 (en) 2-Amino-4-heteroarylethyl-thiazoline derivatives and their use as inhibitors of inducible no-synthase
CY1106822T1 (el) Κρυσταλλικη μορφη ενος παραγωγου ριβοφουρανοσυλουροναμιδιου, αγωνιστης υποδοχεα α2α αδενοσινης του ανθρωπου
AU2003232719A1 (en) Novel crystalline forms of valacyclovir hydrochloride
IL172006A0 (en) Novel crystalline forms of valacyclovir hydrochloride
AU2003289995A1 (en) Anhydrous crystalline form of valacyclovir hydrochloride
DE50305560D1 (de) Perlenkette
IL162983A (en) Use of imatinib for the manufacture of pharmaceutical compositions for the treatment of rheumatoid arthritis
USD523761S1 (en) Watch
DOP2002000527A (es) Forma de farmaco cristalina.
CA2452253A1 (en) Novel crystal of arylethenesulfonamide derivative and preparation process thereof
WO2004026930A3 (en) The method for reducing inflammation using sti-571 or its salt
DOP2002000526A (es) Combinacion de una forma de farmaco cristalina y una sal de tiotropio.